Ribbon Bio
Making The Impossible Possible
Making The Impossible Possible
Ribbon Biolabs:
Ribbon Biolabs, a biotech start-up founded in 2018 and headquartered in Austria, is revolutionizing DNA synthesis with its innovative approach. The company aims to develop a cost-efficient platform for error-proof DNA synthesis, enabling the production of long and complex DNA molecules. This breakthrough technology has the potential to drive a new generation of biopharmaceutical processes and other synthetic biology products.
The company recently received a substantial €18.00M Series A investment on 31 January 2022 from a group of prominent investors including Tecnet Equity, Hadean Partners, Helicase Venture, Lansdowne Partners, and xista science ventures.
Ribbon Biolabs prides itself on its international and highly motivated team based in Vienna, constantly seeking new talents to propel the company to the next level. With its slogan "Give Life To Possibilities," Ribbon Biolabs is poised to make a significant impact in the biotechnology industry and beyond.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | €18.00M | 5 |
|
31 Jan 2022 |
| Seed Round | Unknown | 2 |
|
08 Mar 2019 |
No recent news or press coverage available for Ribbon Bio.
We care about your data, and we'd love to use cookies make your experience better.
